Cytodyn Inc CYDY:OTCQB

RT Quote | Exchange | USD
Last | 10/15/21 EDT
1.42UNCH (UNCH)
52 week range
1.25 - 7.40
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.42
  • 52 Week High7.40
  • 52 Week High Date02/02/21
  • 52 Week Low1.25
  • 52 Week Low Date09/09/21

Key Stats

  • Market Cap900.49M
  • Shares Out634.15M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.87
  • YTD % Change-73.65

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.42
  • 52 Week High7.40
  • 52 Week High Date02/02/21
  • 52 Week Low1.25
  • 52 Week Low Date09/09/21
  • Market Cap900.49M
  • Shares Out634.15M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.87
  • YTD % Change-73.65

RATIOS/PROFITABILITY

  • EPS (TTM)-0.27
  • P/E (TTM)-5.34
  • Fwd P/E (NTM)-7.89
  • EBITDA (TTM)-92.75M
  • ROE (TTM)-566.11%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-298.54%

EVENTS

  • Earnings Date01/09/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cytodyn Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CytoDyn Inc. is a biotechnology company that is focused on developing treatments for multiple therapeutic indications using leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. The CCR5 receptor is a protein located on the surface of various cells including white blood cells and cancer cells. The CCR5 receptor is also the co-receptor needed for certain strains of human immunodeficiency virus (HIV) to infect healthy T-cells. The Company also completed...
Scott Kelly M.D.
Chairman
Nader Pourhassan Ph.D.
President
Christopher Recknor M.D.
Chief Operating Officer
Antonio Migliarese
Chief Financial Officer
Nitya Ray Ph.D.
Chief Technology Officer
Arian Colachis J.D.
Vice President
Address
1111 Main St Ste 660
Vancouver, WA
98660-2970
United States

Top Peers

SYMBOLLASTCHG%CHG
KRON
Kronos Bio Inc
16.78+0.36+2.19%
KROS
Keros Therapeutics Inc
38.99-0.83-2.08%
PRAX
Praxis Precision Medicines Inc
20.01+0.96+5.04%
SNDX
Syndax Pharmaceuticals Inc
18.59+0.10+0.54%
PHAT
Phathom Pharmaceuticals Inc
32.51-0.23-0.70%
STOK
Stoke Therapeutics Inc
23.52-0.52-2.16%